Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120423) titled 'Medium- to Long-Term Effects of IL-17/23 Pathway-Targeted Therapy on Metabolic Parameters in Patients with Psoriasis: A Single-Center Retrospective Study' on March 13.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University
Condition:
Plaque psoriasis
Intervention:
The group treated with IL-17 pathway-targeted biologics:None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-03-20
Target Sample Size: The group treated with IL-17 pathway-targeted biologics:200;The group treated with IL-23 pathwa...